當(dāng)前位置：
GlycoTech公司碳水化合物試劑一級代理
更新時間：2018-07-17
點擊次數(shù)：2286
GlycoTech公司成立于1991年，如今是專注于糖綴合物的生物功能和醫(yī)學(xué)應(yīng)用的重要公司之一。公司建立了自主研發(fā)項目，并獲多項。 GlycoTech通過目錄業(yè)務(wù)建立了罕見碳水化合物試劑庫和技術(shù)。
GlycoTech與Novartis公司在研發(fā)用于防止移植引發(fā)的再灌注損傷中淋巴細(xì)胞從血流中外滲的強(qiáng)效拮抗劑-碳水化合物配體小分子模擬物-方面已持續(xù)合作了六年。另外，GlycoTech公司近授權(quán)給Chiron公司，同意其在世界范圍內(nèi)銷售使用GlycoTech公司的抗碳水化合物腫瘤標(biāo)志物的癌癥診斷產(chǎn)品。GlycoTech公司還與NIH，賓夕法尼亞大學(xué)，羅切斯特大學(xué)和芝加哥神經(jīng)手術(shù)和神經(jīng)研究所建立了研究合作協(xié)議。
GlycoTech公司化合物和試劑業(yè)務(wù)部門的目標(biāo)是為科學(xué)家提供技術(shù)和試劑，使碳水化合物研究擴(kuò)展到細(xì)胞生物學(xué)，免疫學(xué)，神經(jīng)生物學(xué)和分子生物學(xué)等其他領(lǐng)域。公司目錄的部分包括科學(xué)家撰寫的涵蓋糖生物學(xué)主題的實驗方法。下一部分包括按照前一部分實驗方法就可以使即使不專注于糖生物學(xué)的實驗室做糖生物學(xué)實驗的多種特殊的碳水化合物試劑。GlycoTech公司的長遠(yuǎn)目標(biāo)是將公司的技術(shù)和試劑用于基于糖綴合物和其受體相互作用基礎(chǔ)上，發(fā)現(xiàn)碳水化合物新生物功能的研究上。
產(chǎn)品類別：癌癥診斷產(chǎn)品，人選擇蛋白，碳水化合物多聚物，碳水化合物抗體，HAS/BSA綴合物，細(xì)胞黏附裝置，人內(nèi)皮細(xì)胞，碳水化合物/試劑，碳水化合物吸附劑，實驗方法
| 合成碳水化合物聚和物和探針（Synthetic Carbohydrate Polymers and Probes） | |||
| 單價生物素化探針（Univalent Biotinylated Probes） | |||
| 品名 | 貨號 | 規(guī)格 | |
| HOCH2(HOCH)4CH2NH-biotin | 02-000 | 0.5 mg | |
| 單糖（Monosaccharides） | |||
| a-D-Glc-sp-biotin | 02-001 | 1 mg | |
| b-D-Glc-sp-biotin | 02-002 | 1 mg | |
| a-D-Gal-sp-biotin | 02-003 | 1 mg | |
| b-D-Gal-sp-biotin | 02-004 | 1 mg | |
| a-D-Man-sp-biotin | 02-005 | 1 mg | |
| a-D-Man-6-phosphate-sp-biotin | 02-006 | 1 mg | |
| a-L-Fuc-sp-biotin | 02-007 | 1 mg | |
| a-L-Rha-sp-biotin | 02-008 | 1 mg | |
| b-GlcNAc-sp-biotin | 02-009 | 1 mg | |
| a-GalNAc-sp-biotin | 02-010 | 1 mg | |
| b-GalNAc-sp-biotin | 02-011 | 1 mg | |
| a-Neuc-sp-biotin | 02-012 | 1 mg | |
| Neuca2-sp-biotin (sp=-OCH2C6H4-p-NHCOCH2-) | 02-013 | 1 mg | |
| Neucb2-sp-biotin (sp=-OCH2C6H4-p-NHCOCH2-) | 02-103 | 1 mg | |
| MDP-sp-biotin | 02-014 | 1 mg | |
| b-D-Gal-3-sulfate-sp-biotin | 02-015 | 1 mg | |
| 6-HSO3GlcNAcb-sp-biotin | 02-016 | 1 mg | |
| b-D-Man-sp-biotin | 02-050 | 1 mg | |
| Neu5Gca-sp-biotin | 02-051 | 1 mg | |
| 3-HSO3GlcAb-sp-biotin | 02-099 | 1 mg | |
| 3-HSO3-GalNAcb-sp-biotin | 02-104 | 1 mg | |
| 雙糖（Disaccharides） | |||
| Blood type A: GalNAca1-3Galb-sp-biotin | 02-017 | 1 mg | |
| Blood type B: Gala1-3Galb-sp-biotin | 02-018 | 1 mg | |
| Blood Type H: Fuca1-2Galb-sp-biotin | 02-019 | 1 mg | |
| Galb1-3GlcNAcb-sp-biotin (Lec-sp-biotin) | 02-020 | 1 mg | |
| Galb1-4Glcb-sp-biotin (Lac-sp-biotin) | 02-021 | 1 mg | |
| Galb1-4GlcNAcb-sp-biotin (LacNAc-sp-biotin) | 02-022 | 1 mg | |
| Galb1-3GalNAca-sp-biotin | 02-023 | 1 mg | |
| Fuca1-3GlcNAcb-sp-biotin | 02-024 | 1 mg | |
| Fuca1-3GlcNAcb-sp-biotin | 02-025 | 1 mg | |
| GalNAca1-3GalNAcb-sp-biotin | 02-026 | 1 mg | |
| GalNAca1-3GalNAca-sp-biotin | 02-027 | 1 mg | |
| Gala1-3GalNAca-sp-biotin | 02-028 | 1 mg | |
| Galb1-3GalNAcb-sp-biotin | 02-029 | 1 mg | |
| Gala1-3GalNAcb-sp-biotin | 02-030 | 1 mg | |
| Galb1-3Galb-sp-biotin | 02-031 | 1 mg | |
| GlcNAcb1-3Galb1-sp-biotin | 02-052 | 1 mg | |
| Gala1-4GlcNAcb-sp-biotin (a-LacNAc-PAA) | 02-053 | 1 mg | |
| Glca1-4Glcb-sp-biotin | 02-054 | 1 mg | |
| Galb1-3GalNAca-sp-biotin (sp=-p-OC6H4-) | 02-055 | 1 mg | |
| Gala1-2Galb-sp-biotin | 02-056 | 1 mg | |
| GlcNAcb1-4GlcNAcb-sp-biotin | 02-057 | 1 mg | |
| GlcNAcb1-4GlcNAcb-sp-biotin (sp=-NHCOCH2NH-) | 02-058 | 1 mg | |
| Neuca2-6GalNAca-sp-biotin | 02-059 | 0.5 mg | |
| H(type 3)-sp-biotin | 02-060 | 1 mg | |
| 3’-HSO3LacNAc-sp-biotin | 02-061 | 1 mg | |
| 3’-HSO3Galb1-3GlcNAc-sp-biotin | 02-062 | 1 mg | |
| Gala1-6Glc-sp-biotin | 02-063 | 1 mg | |
| (Neuca2-8)2-sp-biotin | 02-064 | 1 mg | |
| Galb1-2Galb-sp-biotin | 02-065 | 1 mg | |
| 6-HSO3LacNAc-sp-biotin | 02-066 | 1 mg | |
| 3`-HSO3Galb1-3GalNAca-sp-biotin | 02-069 | 1 mg | |
| GalNAcb1-3GalNAcb-sp-biotin | 02-070 | 1 mg | |
| GlcNAcb1-3GalNAca-sp-biotin | 02-071 | 1 mg | |
| GlcNAcb1-6GalNAca-sp-biotin | 02-072 | 1 mg | |
| Neuca2-6Galb-sp-biotin | 02-105 | 0.5 mg | |
| Fucb1-3GlcNAcb-sp-biotin | 02-106 | 1 mg | |
| Neu5Gca2-6GalNAca-sp-biotin | 02-107 | 0.5 mg | |
| Neucb2-6GalNAca-sp-biotin | 02-108 | 0.5 mg | |
| Neuca2-3GalNAca-sp-biotin | 02-109 | 0.5 mg | |
| 三糖（Trisaccharides） | |||
| Blood type A (tri)-sp-biotin | 02-032 | 1 mg | |
| Blood type A (tri)-sp-biotin, sp=(CH2)3NHCO(CH2)5NH- | 02-084 | 1 mg | |
| Blood type B (tri)-sp-biotin | 02-033 | 1 mg | |
| Blood type B (tri)-sp-biotin, sp=(CH2)3NHCO(CH2)5NH- | 02-085 | 1 mg | |
| H(type 2)-sp-biotin | 02-034 | 1 mg | |
| Lea-sp-biotin | 02-035 | 1 mg | |
| Lex-sp-biotin | 02-036 | 1 mg | |
| Led-sp-biotin | 02-037 | 1 mg | |
| Neuca2-3Galb1-4Glc-sp-biotin | 02-038 | 0.5 mg | |
| Neuca2-6Galb1-4Glc-sp-biotin | 02-039 | 0.5 mg | |
| 3’-HSO3Lea-sp-biotin | 02-040 | 0.5 mg | |
| 3’-HSO3Lex-sp-biotin | 02-041 | 0.5 mg | |
| Galb1-4Galb1-4Glcb-sp-biotin | 02-073 | 1 mg | |
| GalNAcb1-4Galb1-4Glcb-sp-biotin | 02-074 | 1 mg | |
| Gala1-3Galb1-4Glc-sp-biotin | 02-075 | 1 mg | |
| GlcNAcb1-2Galb1-3GalNAca-sp-biotin | 02-076 | 1 mg | |
| Neuca2-3Galb1-4GlcNAcb-sp-biotin | 02-077 | 0.5 mg | |
| Neuca2-3Galb1-3GlcNAc-sp-biotin | 02-078 | 0.5 mg | |
| Gala1-3Galb1-4GlcNAc-sp-biotin | 02-079 | 1 mg | |
| GlcNAca1-3Galb1-3GalNAca-sp-biotin | 02-080 | 1 mg | |
| (Neuca2-8)3-sp-biotin | 02-081 | 1 mg | |
| GlcNAcb1-3Galb1-3GalNAca-sp-biotin | 02-082 | 1 mg | |
| GlcNAcb1-6(Galb1-3)GalNAca-sp-biotin | 02-083 | 1 mg | |
| GlcNAcb1-3Galb1-4Glcb-sp-biotin | 02-087 | 1 mg | |
| Neuca2-3Galb1-3GalNAca-sp-biotin | 02-088 | 0.5 mg | |
| GlcNAcb1-3(GlcNAcb1-6)GalNAca-sp-biotin | 02-089 | 1 mg | |
| Mana1-3(Mana1-6)Man-sp-biotin | 02-101 | 1 mg | |
| Gala1-4Galb1-4Glcb-sp-biotin | 02-102 | 1 mg | |
| Gala1-4Galb1-4GlcNAcb-sp-biotin | 02-110 | 1 mg | |
| GlcNAcb1-4(GlcNAcb1-6)GalNAca-sp-biotin | 02-111 | 1 mg | |
| GlcNAcb1-4GlcNAcb1-4GlcNAcb-sp-biotin | 02-112 | 1 mg | |
| (sp=-NHCOCH2NH-) | |||
| Galb1-3(Neuca2-6)GalNAca-sp-biotin | 02-113 | 0.5 mg | |
| Galb1-3(Neucb2-6)GalNAca-sp-biotin | 02-114 | 1 mg | |
| Neuca2-3(Neuca2-6)GalNAca-sp-biotin | 02-115 | 0.5 mg | |
| Galb1-4GlcNAcb1-3GalNAca-sp-biotin | 02-116 | 1 mg | |
| Galb1-4GlcNAcb1-6GalNAca-sp-biotin | 02-117 | 1 mg | |
| 四糖或更多低聚糖（Tetra- or more Oligosaccharides） | |||
| Leb-sp-biotin | 02-042 | 1 mg | |
| Ley-sp-biotin | 02-043 | 1 mg | |
| Sialyl Lea-sp-biotin | 02-044 | 0.5 mg | |
| Sialyl Lex-sp-biotin | 02-045 | 0.5 mg | |
| GlcNAcb1-3(GlcNAcb1-6)Galb1-4Glcb1-sp-biotin | 02-090 | 1 mg | |
| A(type 2)-sp-biotin | 02-091 | 1 mg | |
| B(type 2)-sp-biotin | 02-092 | 1 mg | |
| Gala1-3Galb1-4(Fuca1-3)GlcNAcb-sp-biotin | 02-093 | 1 mg | |
| 6(Gal)-HSO3SiaLex-sp-biotin | 02-094 | 0.25 mg | |
| 6(GlcNAc)-HSO3SiaLex-sp-biotin | 02-095 | 0.25 mg | |
| Galb1-3GlcNAcb1-3Galb1-4Glc-sp-biotin | 02-097 | 0.5 mg | |
| Galb1-4GlcNAcb1-3Galb1-4Glc-sp-biotin | 02-098 | 0.5 mg | |
| Gala1-3(Gala1-4)Galb1-4GlcNAcb-sp-biotin | 02-118 | 1 mg | |
| GalNAca1-4(Fuca1-2)Galb1-4GlcNAcb-sp-biotin | 02-119 | 1 mg | |
| GalNAcb1-3(Fuca1-2)Galb1-4GlcNAcb-sp-biotin | 02-120 | 1 mg | |
| Gala1-4(Fuca1-2)Galb1-4GlcNAcb-sp-biotin | 02-121 | 1 mg | |
| GlcNAcb1-3(GlcNAcb1-6)GlcNAcb1-4GalNAca-sp-biotin | 02-122 | 1 mg | |
| Galb1-3(Galb1-4GlcNAcb1-6)GalNAca-sp-biotin | 02-123 | 1 mg | |
| Fuca1-2(Galb1-4GalNAca1-3)Galb1-4GlcNAcb-sp-biotin | 02-124 | 1 mg | |
| Galb1-4GlcNAcb1-3(Galb1-4GlcNAcb1-6)GalNAca-sp-biotin | 02-125 | 1 mg | |
| (SA2-6G-GN-M)2-3,6-M-GN-GNb-sp-biotin | 02-126 | 0.5 mg | |
| sp=-NHCOCH2NH- | |||
| SA=Neuc, G= Gal, GN=GlcNAc, M=Man | |||
| 多價聚合物（M*lent Polymers） | |||
| 品名 | 貨號 | 規(guī)格 | |
| HOCH2(HOCH)4CH2NH-PAA | 08-000 | 0.5 mg | |
| 單糖（Monosaccharides） | |||
| a-D-Glucose-PAA | 08-001 | 1 mg | |
| b-D-Glucose-PAA | 08-002 | 1 mg | |
| a-D-Galactose-PAA | 08-003 | 1 mg | |
| b-D-Galactose-PAA | 08-004 | 1 mg | |
| a-D-Mannose-PAA | 08-005 | 1 mg | |
| a-D-Man-6-phosphate-PAA | 08-006 | 1 mg | |
| a-L-Fucose-PAA | 08-007 | 1 mg | |
| a-L-Rhamnose-PAA | 08-008 | 1 mg | |
| b-GlcNAc-PAA | 08-009 | 1 mg | |
| a-GalNAc-PAA | 08-010 | 1 mg | |
| b-GalNAc-PAA | 08-011 | 1 mg | |
| a-Neuc-PAA | 08-012 | 1 mg | |
| a-Neuc-OCH2C6H4-p-NHCOCH2-PAA | 08-013 | 1 mg | |
| MDP-PAA | 08-014 | 1 mg | |
| b-D-Gal-3-sulfate-PAA | 08-015 | 1 mg | |
| b-D-GlcNAc-6-sulfate-PAA | 08-016 | 1 mg | |
| b-D-Man-PAA | 08-050 | 1 mg | |
| Neu5Gca-PAA | 08-051 | 1 mg | |
| 3-HSO3-GalNAcb-PAA | 08-104 | 1 mg | |
| 雙糖（Disaccharides） | |||
| Blood type A: GalNAca1-3Galb-PAA | 08-017 | 1 mg | |
| Blood type B: Gala1-3Galb-PAA | 08-018 | 1 mg | |
| Blood type H: Fuca1-2Galb-PAA | 08-019 | 1 mg | |
| Galb1-3GlcNAcb-PAA (Lec-PAA) | 08-020 | 1 mg | |
| Galb1-4Glcb-PAA (Lac-PAA) | 08-021 | 1 mg | |
| Galb1-4GlcNAcb-PAA (LacNAc-PAA) | 08-022 | 1 mg | |
| Galb1-3GalNAca-PAA | 08-023 | 1 mg | |
| Fuca1-3GlcNAcb-PAA | 08-024 | 1 mg | |
| Fuca1-4GlcNAcb-PAA | 08-025 | 1 mg | |
| GalNAca1-3GalNAcb-PAA | 08-026 | 1 mg | |
| GalNAca1-3GalNAca-PAA | 08-027 | 1 mg | |
| Gala1-3GalNAca-PAA | 08-028 | 1 mg | |
| Galb1-3GalNAcb-PAA | 08-029 | 1 mg | |
| Gala1-3GalNAcb-PAA | 08-030 | 1 mg | |
| Galb1-3Galb-PAA | 08-031 | 1 mg | |
| GlcNAcb1-3Galb-PAA | 08-052 | 1 mg | |
| Gala1-4GlcNAcb-PAA, (a-LacNAc-PAA) | 08-053 | 1 mg | |
| Glca1-4Glcb-PAA (maltose) | 08-054 | 1 mg | |
| Galb1-3GalNAca-PAA, sp=-p-OC6H4- | 08-055 | 1 mg | |
| Gala1-2Galb-PAA | 08-056 | 1 mg | |
| GlcNAcb1-4GlcNAcb-PAA | 08-057 | 1 mg | |
| GlcNAcb1-4GlcNAcb-PAA, sp=-NHCOCH2NH- | 08-058 | 1 mg | |
| Neuca2-6GalNAca-PAA | 08-059 | 0.5 mg | |
| H(type 3)-PAA | 08-060 | 1 mg | |
| 3`-HSO3LacNAc-PAA | 08-061 | 1 mg | |
| 3`-HSO3Galb-3GlcNAcb-PAA | 08-062 | 1 mg | |
| Gala1-6Glcb-PAA (melibiose) | 08-063 | 1 mg | |
| Neuca2-8Neuca-sp**-PAA, (Neuc)2 | 08-064 | 1 mg | |
| Galb1-2Galb-PAA | 08-065 | 1 mg | |
| 6-HSO3Galb1-4GlcNAcb-PAA | 08-066 | 1 mg | |
| Neuca2-3Gal-PAA | 08-067 | 1 mg | |
| 6`-HSO3Galb1-4GlcNAcb-PAA | 08-068 | 1 mg | |
| 3`-HSO3Galb1-3GalNAca-PAA | 08-069 | 1 mg | |
| GalNAcb1-3GalNAcb-PAA | 08-070 | 1 mg | |
| GlcNAcb1-3GalNAca-PAA | 08-071 | 1 mg | |
| GlcNAcb1-6GalNAca-PAA | 08-072 | 1 mg | |
| Neuca2-6Galb-PAA | 08-105 | 0.5 mg | |
| Fucb1-3GlcNAcb-PAA | 08-106 | 1 mg | |
| Neu5Gca2-6GalNAca-PAA | 08-107 | 0.5 mg | |
| Neucb2-6GalNAca-PAA | 08-108 | 0.5 mg | |
| Neuca2-3GalNAca-PAA | 08-109 | 0.5 mg | |
| 三糖（Trisaccharides） | |||
| Blood type A (tri)-PAA | 08-032 | 1 mg | |
| Blood type A (tri)-PAA, sp=(CH2)3NHCO(CH2)5NH- | 08-084 | 1 mg | |
| Blood type B (tri)-PAA | 08-033 | 1 mg | |
| Blood type B (tri)-PAA, sp=(CH2)3NHCO(CH2)5NH- | 08-085 | 1 mg | |
| H (type 2)-PAA | 08-034 | 1 mg | |
| Lea-PAA | 08-035 | 1 mg | |
| Lex-PAA | 08-036 | 1 mg | |
| Led (H type 1)-PAA | 08-037 | 1 mg | |
| 3’-Sialyllactose-PAA | 08-038 | 0.5 mg | |
| 6’-Sialyllactose-PAA | 08-039 | 0.5 mg | |
| 3’-HSO3Lea-PAA | 08-040 | 0.5 mg | |
| 3’-HSO3Lex-PAA | 08-041 | 0.5 mg | |
| Galb1-4Galb1-4Glcb-PAA | 08-073 | 1 mg | |
| GalNAcb1-4Galb1-4Glcb-PAA | 08-074 | 1 mg | |
| Gala1-3Galb1-4Glcb-PAA | 08-075 | 1 mg | |
| GlcNAcb1-2Galb1-3GalNAca-PAA | 08-076 | 1 mg | |
| Neuca2-3Galb1-4GlcNAcb-PAA | 08-077 | 0.5 mg | |
| 3`SiaLec-PAA | 08-078 | 0.5 mg | |
| Gala1-3Galb1-4GlcNAcb-PAA | 08-079 | 1 mg | |
| GlcNAca1-3Galb1-3GalNAca-PAA | 08-080 | 1 mg | |
| Neuca2-8Neuca2-8Neuca-sp**-PAA, (Neuc)3 | 08-081 | 1 mg | |
| GlcNAcb1-3Galb1-3GalNAca-PAA | 08-082 | 1 mg | |
| Galb1-3(GlcNAcb1-6)GalNAca-PAA | 08-083 | 1 mg | |
| GlcNAcb1-3Galb1-4GlcNAcb-PAA | 08-086 | 1 mg | |
| GlcNAcb1-3Galb1-4Glcb-PAA | 08-087 | 1 mg | |
| Neuca2-3Galb1-3GalNAca-PAA | 08-088 | 0.5 mg | |
| GlcNAcb1-3(GlcNAcb1-6)GalNAca-PAA | 08-089 | 1 mg | |
| Gala1-4Galb1-4GlcNAcb-PAA | 08-110 | 1 mg | |
| GlcNAcb1-4(GlcNAcb1-6)GalNAca-PAA | 08-111 | 1 mg | |
| GlcNAcb1-4GlcNAcb1-4GlcNAcb-PAA | 08-112 | 1 mg | |
| (sp=-NHCOCH2NH-) | |||
| Galb1-3(Neuca2-6)GalNAca-PAA | 08-113 | 0.5 mg | |
| Galb1-3(Neucb2-6)GalNAca-PAA | 08-114 | 0.5 mg | |
| Neuca2-3(Neuca2-6)GalNAca-PAA | 08-115 | 0.5 mg | |
| Galb1-4GlcNAcb1-3GalNAca-PAA | 08-116 | 1 mg | |
| Galb1-4GlcNAcb1-6GalNAca-PAA | 08-117 | 1 mg | |
| 四糖或更多低聚糖（Tetra- and more Oligosaccharides） | |||
| Leb-PAA | 08-042 | 1 mg | |
| Ley-PAA | 08-043 | 1 mg | |
| Sialyl Lea-PAA | 08-044 | 0.5 mg | |
| Sialyl Lex-PAA | 08-045 | 0.5 mg | |
| GlcNAcb1-3(GlcNAcb1-6)Gal?font FACE="Times New Roman" COLOR="#000000" size="3">1-4Glcb-PAA | 08-090 | 1 mg | |
| GalNAca1-3(Fuca1-2)Galb1-4GlcNAcb-PAA | 08-091 | 1 mg | |
| Gala1-3(Fuca1-2)Galb1-4GlcNAcb-PAA | 08-092 | 1 mg | |
| Gala1-3Galb1-4(Fuca1-3)GlcNAcb-PAA | 08-093 | 1 mg | |
| Neuca2-3(6-HSO3)Galb1-4(Fuca1-3)GlcNAcb-PAA (6Gal-HSO3-SiaLex) | 08-094 | 0.25 mg | |
| Neuca2-3Galb1-4(Fuca1-3)(6-HSO3)GlcNAcb-PAA (6GlcNAc-HSO3-SiaLex) | 08-095 | 0.25 mg | |
| Galb1-3GlcNAcb1-3Galb1-4GlcNAcb-PAA | 08-096 | 0.5 mg | |
| Galb1-3GlcNAcb1-3Galb1-4Glcb-PAA | 08-097 | 0.5 mg | |
| Galb1-4GlcNAcb1-3Galb1-4Glcb-PAA | 08-098 | 0.5 mg | |
| (Neuc)5-6-sp-PAA | 08-100 | 1 mg | |
| Gala1-3(Gala1-4)Galb1-4GlcNAcb-PAA | 08-118 | 1 mg | |
| GalNAca1-4(Fuca1-2)Galb1-4GlcNAcb-PAA | 08-119 | 1 mg | |
| GalNAcb1-3(Fuca1-2)Galb1-4GlcNAcb-PAA | 08-120 | 1 mg | |
| Gala1-4(Fuca1-2)Galb1-4GlcNAcb-PAA | 08-121 | 1 mg | |
| GlcNAcb1-3(GlcNAcb1-6)GlcNAcb1-4GalNAca-PAA | 08-122 | 1 mg | |
| Galb1-3(Galb1-4GlcNAcb1-6)GalNAca-PAA | 08-123 | 1 mg | |
| Fuca1-2(Galb1-4GalNAca1-3)Galb1-4GlcNAcb-PAA | 08-124 | 1 mg | |
| Galb1-4GlcNAcb1-3(Galb1-4GlcNAcb1-6)GalNAca-PAA | 08-125 | 1 mg | |
| (SA2-6G-GN-M)2-3,6-M-GN-GNb-PAA | 08-126 | 0.5 mg | |
| sp=-NHCOCH2NH- | |||
| SA=Neuc, G= Gal, GN=GlcNAc, M=Man | |||
| 多價生物素化聚合物（M*lent Biotinylated Polymers） | |||
| 品名 | 貨號 | 規(guī)格 | |
| HOCH2(HOCH)4CH2NH-PAA-biotin | 01-000 | 0.5 mg | |
| 單糖（Monosaccharides） | |||
| a-D-Glucose-PAA-biotin | 01-001 | 1 mg | |
| b-D-Glucose-PAA-biotin | 01-002 | 1 mg | |
| a-D-Galactose-PAA-biotin | 01-003 | 1 mg | |
| b-D-Galactose-PAA-biotin | 01-004 | 1 mg | |
| a-D-Mannose-PAA-biotin | 01-005 | 1 mg | |
| a-D-Man-6-phosphate-PAA-biotin | 01-006 | 1 mg | |
| a-L-Fucose-PAA-biotin | 01-007 | 1 mg | |
| a-L-Rhamnose-PAA-biotin | 01-008 | 1 mg | |
| b-GlcNAc-PAA-biotin | 01-009 | 1 mg | |
| a-GalNAc-PAA-biotin | 01-010 | 1 mg | |
| b-GalNAc-PAA-biotin | 01-011 | 1 mg | |
| a-Neuc-PAA-biotin | 01-012 | 1 mg | |
| a-Neuc-OCH2C6H4-p-NHCOOCH2-PAA-biotin | 01-013 | 1 mg | |
| MDP-PAA-biotin | 01-014 | 1 mg | |
| b-D-Gal-3-sulfate-PAA-biotin | 01-015 | 1 mg | |
| b-D-GlcNAc-6-sulfate-PAA-biotin | 01-016 | 1 mg | |
| b-D-Man-PAA-biotin | 01-050 | 1 mg | |
| Neu5Gca-PAA-biotin | 01-051 | 1 mg | |
| 3-HSO3-GalNAcb-PAA-biotin | 01-104 | 1 mg | |
| 雙糖(Disaccharides) | |||
| Blood type A: GalNAca1-3Galb-PAA-biotin | 01-017 | 1 mg | |
| Blood type B: Gala1-3Galb-PAA-biotin | 01-018 | 1 mg | |
| Blood type H: Fuca1-2Galb-PAA-biotin | 01-019 | 1 mg | |
| Galb1-3GlcNAcb-PAA-biotin (Lec-PAA-biotin) | 01-020 | 1 mg | |
| Galb1-4Glcb-PAA-biotin (Lac-PAA-biotin) | 01-021 | 1 mg | |
| Galb1-4GlcNAcb-PAA-biotin (LacNAc-PAA-biotin) | 01-022 | 1 mg | |
| Galb1-3GalNAca-PAA-biotin | 01-023 | 1 mg | |
| Fuca1-3GlcNAcb-PAA-biotin | 01-024 | 1 mg | |
| Fuca1-4GlcNAcb-PAA-biotin | 01-025 | 1 mg | |
| GalNAca1-3GalNAcb-PAA-biotin | 01-026 | 1 mg | |
| GalNAca1-3GalNAca-PAA-biotin | 01-027 | 1 mg | |
| Gala1-3GalNAca-PAA-biotin | 01-028 | 1 mg | |
| Galb1-3GalNAcb-PAA-biotin | 01-029 | 1 mg | |
| Gala1-3GalNAcb-PAA-biotin | 01-030 | 1 mg | |
| Galb1-3Galb-PAA-biotin | 01-031 | 1 mg | |
| GlcNAcb1-3Galb-PAA-biotin | 01-052 | 1 mg | |
| Gala1-4GlcNAcb-PAA-biotin, (a-LacNAc-PAA-biotin) | 01-053 | 1 mg | |
| Glca1-4Glcb-PAA-biotin (maltose) | 01-054 | 1 mg | |
| Galb1-3GalNAca-PAA-biotin, sp=-p-OC6H4- | 01-055 | 1 mg | |
| Gala1-2Galb-PAA-biotin | 01-056 | 1 mg | |
| GlcNAcb1-4GlcNAcb-PAA-biotin | 01-057 | 1 mg | |
| GlcNAcb1-4GlcNAcb-PAA-biotin, sp=-NHCOCH2NH- | 01-058 | 1 mg | |
| Neuca2-6GalNAca-PAA-biotin | 01-059 | 0.5 mg | |
| H(type 3)-PAA-biotin | 01-060 | 1 mg | |
| 3`-HSO3LacNAc-PAA-biotin | 01-061 | 1 mg | |
| 3-HSO3Galb-3GlcNAcb-PAA-biotin | 01-062 | 1 mg | |
| Gala1-6Glcb-PAA-biotin (melibiose) | 01-063 | 1 mg | |
| Neuca2-8Neuca-sp**-PAA-biotin, (Neuc)2 | 01-064 | 1 mg | |
| Galb1-2Galb-PAA-biotin | 01-065 | 1 mg | |
| 6-HSO3Galb1-4GlcNAcb-PAA-biotin | 01-066 | 1 mg | |
| Neuca2-3Gal-PAA-biotin | 01-067 | 1 mg | |
| 6`-HSO3LacNAc-PAA-biotin | 01-068 | 1 mg | |
| 3`-HSO3TF-PAA-biotin | 01-069 | 1 mg | |
| GalNAcb1-3GalNAcb-PAA-biotin | 01-070 | 1 mg | |
| GlcNAcb1-3GalNAca-PAA-biotin | 01-071 | 1 mg | |
| GlcNAcb1-6GalNAca-PAA-biotin | 01-072 | 1 mg | |
| Neuca2-6Galb-PAA-biotin | 01-105 | 0.5 mg | |
| Fucb1-3GlcNAcb-PAA-biotin | 01-106 | 1 mg | |
| Neu5Gca2-6GalNAca-PAA-biotin | 01-107 | 0.5 mg | |
| Neucb2-6GalNAca-PAA-biotin | 01-108 | 0.5 mg | |
| Neuca2-3GalNAca-PAA-biotin | 01-109 | 0.5 mg | |
| 三糖（Trisaccharides） | |||
| Blood type A (tri)-PAA-biotin | 01-032 | 1 mg | |
| Blood type A (tri)-PAA-biotin, sp=(CH2)3NHCO(CH2)5NH- | 01-084 | 1 mg | |
| Blood type B (tri)-PAA-biotin | 01-033 | 1 mg | |
| Blood type B (tri)-PAA-biotin, sp=(CH2)3NHCO(CH2)5NH- | 01-085 | 1 mg | |
| H (type 2)-PAA-biotin | 01-034 | 1 mg | |
| Lea-PAA-biotin | 01-035 | 1 mg | |
| Lex-PAA-biotin | 01-036 | 1 mg | |
| Led (H type 1)-PAA-biotin | 01-037 | 1 mg | |
| 3’-Sialyllactose-PAA-biotin | 01-038 | 0.5 mg | |
| 6’-Sialyllactose-PAA-biotin | 01-039 | 0.5 mg | |
| 3’HSO3Lea-PAA-biotin | 01-040 | 0.5 mg | |
| 3’HSO3Lex-PAA-biotin | 01-041 | 0.5 mg | |
| Galb1-4Galb1-4Glcb-PAA-biotin | 01-073 | 1 mg | |
| GalNAcb1-4Galb1-4Glcb-PAA-biotin | 01-074 | 1 mg | |
| Gala1-3Galb1-4Glcb-PAA-biotin | 01-075 | 1 mg | |
| GlcNAcb1-2Galb1-3GalNAca-PAA-biotin | 01-076 | 1 mg | |
| Neuca2-3Galb1-4GlcNAcb-PAA-biotin | 01-077 | 0.5 mg | |
| 3`SiaLec-PAA-biotin | 01-078 | 0.5 mg | |
| Gala1-3Galb1-4GlcNAcb-PAA-biotin, sp=-NHCOCH2NH- | 01-079 | 1 mg | |
| GlcNAca1-3Galb1-3GalNAca-PAA-biotin | 01-080 | 1 mg | |
| Neuca2-8Neuca2-8Neuca-sp**-PAA-biotin, (Neuc)3 | 01-081 | 1 mg | |
| GlcNAcb1-3Galb1-3GalNAca-PAA-biotin | 01-082 | 1 mg | |
| Galb1-3(GlcNAcb1-6)GalNAca-PAA-biotin | 01-083 | 1 mg | |
| GlcNAcb1-3Galb1-4GlcNAcb-PAA-biotin | 01-086 | 1 mg | |
| GlcNAcb1-3Galb1-4Glcb-PAA-biotin | 01-087 | 1 mg | |
| Neuca2-3Galb1-3GalNAca-PAA-biotin | 01-088 | 0.5 mg | |
| GlcNAcb1-3(GlcNAcb1-6)GalNAca-PAA-biotin | 01-089 | 1 mg | |
| Gala1-4Galb1-4GlcNAcb-PAA-biotin | 01-110 | 1 mg | |
| GlcNAcb1-4(GlcNAcb1-6)GalNAca-PAA-biotin | 01-111 | 1 mg | |
| GlcNAcb1-4GlcNAcb1-4GlcNAcb-PAA-biotin | 01-112 | 1 mg | |
| (sp=-NHCOCH2NH-) | |||
| Galb1-3(Neuca2-6)GalNAca-PAA-biotin | 01-113 | 0.5 mg | |
| Galb1-3(Neucb2-6)GalNAca-PAA-biotin | 01-114 | 0.5 mg | |
| Neuca2-3(Neuca2-6)GalNAca-PAA-biotin | 01-115 | 0.5 mg | |
| Galb1-4GlcNAcb1-3GalNAca-PAA-biotin | 01-116 | 1 mg | |
| Galb1-4GlcNAcb1-6GalNAca-PAA-biotin | 01-117 | 1 mg | |
| 四糖或更多低聚糖（Tetra- and more Oligosaccharides） | |||
| Leb-PAA-biotin | 01-042 | 1 mg | |
| Ley-PAA-biotin | 01-043 | 1 mg | |
| Sialyl Lea-PAA-biotin | 01-044 | 0.5 mg | |
| Sialyl Lex-PAA-biotin | 01-045 | 0.5 mg | |
| GlcNAcb1-3(GlcNAcb1-6)Galb1-4Glcb-PAA-biotin | 01-090 | 1 mg | |
| GalNAca1-3(Fuca1-2)Galb1-4GlcNAc-PAA-biotin | 01-091 | 1 mg | |
| Gala1-3(Fuca1-2)Galb1-4GlcNAc-PAA-biotin | 01-092 | 1 mg | |
| Gala1-3Galb1-4(Fuca1-3)GlcNAcb-PAA-biotin | 01-093 | 1 mg | |
| Neuca2-3(6-HSO3)Galb1-4(Fuca1-3)GlcNAcb-PAA-biotin (6Gal-HSO3-SiaLex) | 01-094 | 0.25 mg | |
| Neuca2-3Galb1-4(Fuca1-3)(6-HSO3)GlcNAcb-PAA-biotin (6GlcNAc-HSO3-SiaLex) | 01-095 | 0.25 mg | |
| Galb1-3GlcNAcb1-3Galb1-4GlcNAcb-PAA-biotin | 01-096 | 0.5 mg | |
| Galb1-3GlcNAcb1-3Galb1-4Glcb-PAA-biotin | 01-097 | 0.5 mg | |
| Galb1-4GlcNAcb1-3Galb1-4Glcb-PAA-biotin | 01-098 | 0.5 mg | |
| (Neuc)5-6-sp-PAA-biotin | 01-100 | 1.0 mg | |
| Gala1-3(Gala1-4)Galb1-4GlcNAcb-PAA-biotin | 01-118 | 1 mg | |
| GalNAca1-4(Fuca1-2)Galb1-4GlcNAcb-PAA-biotin | 01-119 | 1 mg | |
| GalNAcb1-3(Fuca1-2)Galb1-4GlcNAcb-PAA-biotin | 01-120 | 1 mg | |
| Gala1-4(Fuca1-2)Galb1-4GlcNAcb-PAA-biotin | 01-121 | 1 mg | |
| GlcNAcb1-3(GlcNAcb1-6)GlcNAcb1-4GalNAca-PAA-biotin | 01-122 | 1 mg | |
| Galb1-3(Galb1-4GlcNAcb1-6)GalNAca-PAA-biotin | 01-123 | 1 mg | |
| Fuca1-2(Galb1-4GalNAca1-3)Galb1-4GlcNAcb-PAA-biotin | 01-124 | 1 mg | |
| Galb1-4GlcNAcb1-3(Galb1-4GlcNAcb1-6)GalNAca-PAA-biotin | 01-125 | 1 mg | |
| (SA2-6G-GN-M)2-3,6-M-GN-GNb-PAA-biotin | 01-126 | 0.5 mg | |
| sp=-NHCOCH2NH- | |||
| SA=Neuc, G= Gal, GN=GlcNAc, M=Man | |||
| 成套的碳水化合物聚和物（Sets of Carbohydrate Polymers） | |||
| 品名 | 貨號 | 規(guī)格 | |
| ß-GlcNAc-PAA SET | 05-001 | 3x1 mg | |
| 3’-HSO3Gal-PAA SET | 05-002 | 3x1 mg | |
| Blood type A: GalNAc1-3Galß-PAA SET | 05-003 | 3x1 mg | |
| Blood type B: Gal1-3Galß-PAA SET | 05-004 | 3x1 mg | |
| Blood type O: Fuc1-2Galß-PAA SET | 05-005 | 3x1 mg | |
| Blood type A (tri)-PAA SET | 05-006 | 6x1 mg | |
| Blood type B (tri)-PAA SET | 05-007 | 6x1 mg | |
| Lea-PAA SET | 05-008 | 3x0.1 mg | |
| Lex-PAA SET | 05-009 | 3x0.1 mg | |
| 3’-HSO3Lea-PAA SET | 05-010 | 3x0.1 mg | |
| 3’-HSO3Lex-PAA SET | 05-011 | 3x0.1 mg | |
| Leb-PAA SET | 05-012 | 3x0.1 mg | |
| Ley-PAA SET | 05-013 | 3x0.1 mg | |
| Sialyl Lea-PAA SET | 05-014 | 5x0.1 mg | |
| Sialyl Lex-PAA SET | 05-015 | 5x0.1 mg | |
| Lac-PAA SET | 05-016 | 3x1 mg | |
| 多價熒光素化聚合物（M*lent Fluoresceinated Polymers） | |||
| 品名 | 貨號 | 規(guī)格 | |
| HOCH2(HOCH)4CH2NH-PAA-fluor. | 03-000 | 0.4 mg | |
| 單糖（Monosaccharides） | |||
| a-D-Glucose-PAA-fluor. | 03-001 | 0.4 mg | |
| b-D-Glucose-PAA-fluor. | 03-002 | 0.4 mg | |
| a-D-Galactose-PAA-fluor. | 03-003 | 0.4 mg | |
| b-D-Galactose-PAA-fluor | 03-004 | 0.4 mg | |
| a-D-Mannose-PAA-fluor. | 03-005 | 0.4 mg | |
| a-D-Man-6-phosphate-PAA-fluor. | 03-006 | 0.4 mg | |
| a-L-Fucose-PAA-fluor. | 03-007 | 0.4 mg | |
| a-L-Rhamnose-PAA-fluor. | 03-008 | 0.4 mg | |
| b-GlcNAc-PAA-fluor. | 03-009 | 0.4 mg | |
| a-GalNAc-PAA-fluor. | 03-010 | 0.4 mg | |
| b-GalNAc-PAA-fluor. | 03-011 | 0.4 mg | |
| a-Neuc-PAA-fluor. | 03-012 | 0.4 mg | |
| a-Neuc-OCH2C6H4-p-NHCOOCH2-PAA-fluor. | 03-013 | 0.4 mg | |
| MDP-PAA-fluor. | 03-014 | 0.4 mg | |
| b-D-Gal-3-sulfate-PAA-fluor. | 03-015 | 0.4 mg | |
| b-D-GlcNAc-6-sulfate-PAA-fluor. | 03-016 | 0.4 mg | |
| b-D-Man-PAA-fluor. | 03-050 | 0.4 mg | |
| Neu5Gca-PAA-fluor. | 03-051 | 0.4 mg | |
| 3-HSO3-GalNAcb-PAA-fluor. | 03-104 | 0.4 mg | |
| 雙糖（Disaccharides） | |||
| Blood type A: GalNAca1-3Galb-PAA-fluor. | 03-017 | 0.4 mg | |
| Blood type B: Gala1-3Galb-PAA-fluor. | 03-018 | 0.4 mg | |
| Blood type H: Fuca1-2Galb-PAA-fluor. | 03-019 | 0.4 mg | |
| Galb1-3GlcNAcb-PAA-fluor. (Lec-PAA-fluor.) | 03-020 | 0.4 mg | |
| Galb1-4Glcb-PAA-fluor. (Lac-PAA-fluor.) | 03-021 | 0.4 mg | |
| Galb1-4GlcNAcb-PAA-fluor. (LacNAc-PAA-flour.) | 03-022 | 0.4 mg | |
| Galb1-3GalNAca-PAA-fluor. | 03-023 | 0.4 mg | |
| Fuca1-3GlcNAcb-PAA-fluor. | 03-024 | 0.4 mg | |
| Fuca1-4GlcNAcb-PAA-fluor. | 03-025 | 0.4 mg | |
| GalNAca1-3GalNAcb-PAA-fluor. | 03-026 | 0.4 mg | |
| GalNAca1-3GalNAca-PAA-fluor. | 03-027 | 0.4 mg | |
| Gala1-3GalNAca-PAA-fluor. | 03-028 | 0.4 mg | |
| Galb1-3GalNAcb-PAA-fluor. | 03-029 | 0.4 mg | |
| Gala1-3GalNAcb-PAA-fluor. | 03-030 | 0.4 mg | |
| Galb1-3Galb-PAA-fluor. | 03-031 | 0.4 mg | |
| GlcNAcb1-3Galb-PAA-fluor. | 03-052 | 0.4 mg | |
| Gala1-4GlcNAcb-PAA-fluor., (a-LacNAc-PAA-fluor.) | 03-053 | 0.4 mg | |
| Glca1-4Glcb-PAA-fluor. (maltose) | 03-054 | 0.4 mg | |
| Galb1-3GalNAca-PAA-fluor., sp=-p-OC6H4- | 03-055 | 0.4 mg | |
| Gala1-2Galb-PAA-fluor. | 03-056 | 0.4 mg | |
| GlcNAcb1-4GlcNAcb-PAA-fluor. | 03-057 | 0.4 mg | |
| GlcNAcb1-4GlcNAcb-PAA-fluor., sp=-NHCOCH2NH- | 03-058 | 0.4 mg | |
| Neuca2-6GalNAca-PAA-fluor. | 03-059 | 0.2 mg | |
| H(type 3)-PAA-fluor. | 03-060 | 0.4 mg | |
| 3`-HSO3LacNAc-PAA-fluor. | 03-061 | 0.4 mg | |
| 3`-HSO3Galb-3GlcNAcb-PAA-fluor. | 03-062 | 0.4 mg | |
| Gala1-6Glcb-PAA-fluor. (melibiose) | 03-063 | 0.4 mg | |
| Neuca2-8Neuca-sp**-PAA-fluor., (Neuc)2 | 03-064 | 0.4 mg | |
| Galb1-2Galb-PAA-fluor. | 03-065 | 0.4 mg | |
| 6-HSO3Galb1-4GlcNAcb-PAA-fluor. | 03-066 | 0.4 mg | |
| Neuca2-3Gal-PAA-fluor. | 03-067 | 0.4 mg | |
| 6`-HSO3LacNAc-PAA-fluor. | 03-068 | 0.4 mg | |
| 3`-HSO3Galb1-3GalNAca-PAA-fluor. | 03-069 | 0.4 mg | |
| GalNAcb1-3GalNAcb-PAA-fluor. | 03-070 | 0.4 mg | |
| GlcNAcb1-3GalNAca-PAA-fluor. | 03-071 | 0.4 mg | |
| GlcNAcb1-6GalNAca-PAA-fluor. | 03-072 | 0.4 mg | |
| Neuca2-6Galb-PAA-fluor. | 03-105 | 0.2 mg | |
| Fucb1-3GlcNAcb-PAA-fluor. | 03-106 | 0.4 mg | |
| Neu5Gca2-6GalNAca-PAA-fluor. | 03-107 | 0.2 mg | |
| Neucb2-6GalNAca-PAA-fluor. | 03-108 | 0.2 mg | |
| Neuca2-3GalNAca-PAA-fluor. | 03-109 | 0.2 mg | |
| 三糖（Trisaccharides） | |||
| Blood type A (tri)-PAA-fluor. | 03-032 | 0.4 mg | |
| Blood type A (tri)-PAA-fluor., sp=(CH2)3NHCO(CH2)5NH- | 03-084 | 0.4 mg | |
| Blood type B (tri)-PAA-fluor. | 03-033 | 0.4 mg | |
| Blood type B (tri)-PAA-fluor., sp=(CH2)3NHCO(CH2)5NH- | 03-085 | 0.4 mg | |
| H (type 2)-PAA-fluor. | 03-034 | 0.4 mg | |
| Lea-PAA-fluor. | 03-035 | 0.4 mg | |
| Lex-PAA-fluor. | 03-036 | 0.4 mg | |
| Led (H type 1)-PAA-fluor. | 03-037 | 0.4 mg | |
| 3’-Sialyllactose-PAA-fluor. | 03-038 | 0.2 mg | |
| 6’-Sialyllactose-PAA-fluor. | 03-039 | 0.2 mg | |
| 3’-HSO3Lea-PAA-fluor. | 03-040 | 0.2 mg | |
| 3’-HSO3Lex-PAA-fluor. | 03-041 | 0.2 mg | |
| Galb1-4Galb1-4Glcb-PAA-fluor. | 03-073 | 0.4 mg | |
| GalNAcb1-4Galb1-4Glcb-PAA-fluor. | 03-074 | 0.4 mg | |
| Gala1-3Galb1-4Glcb-PAA-fluor. | 03-075 | 0.4 mg | |
| GlcNAcb1-2Galb1-3GalNAca-PAA-fluor. | 03-076 | 0.4 mg | |
| Neuca2-3Galb1-4GlcNAcb-PAA-fluor. | 03-077 | 0.2 mg | |
| 3`SiaLec-PAA-fluor. | 03-078 | 0.2 mg | |
| Gala1-3Galb1-4GlcNAcb-PAA-fluor., sp=-NHCOCH2NH- | 03-079 | 0.4 mg | |
| GlcNAca1-3Galb1-3GalNAca-PAA-fluor. | 03-080 | 0.4 mg | |
| Neuca2-8Neuca2-8Neuca-sp**-PAA-fluor., (Neuc)3 | 03-081 | 0.4 mg | |
| GlcNAcb1-3Galb1-3GalNAca-PAA-fluor. | 03-082 | 0.4 mg | |
| Galb1-3(GlcNAcb1-6)GalNAca-PAA-fluor. | 03-083 | 0.4 mg | |
| GlcNAcb1-3Galb1-4GlcNAcb-PAA-fluor. | 03-086 | 0.4 mg | |
| GlcNAcb1-3Galb1-4Glcb-PAA-fluor. | 03-087 | 0.4 mg | |
| Neuca2-3Galb1-3GalNAca-PAA-fluor. | 03-088 | 0.2 mg | |
| GlcNAcb1-3(GlcNAcb1-6)GalNAca-PAA-fluor. | 03-089 | 0.4 mg | |
| Gala1-4Galb1-4GlcNAcb-PAA-fluor. | 03-110 | 0.4 mg | |
| GlcNAcb1-4(GlcNAcb1-6)GalNAca-PAA-fluor. | 03-111 | 0.4 mg | |
| GlcNAcb1-4GlcNAcb1-4GlcNAcb-PAA-fluor. | 03-112 | 0.4 mg | |
| (sp=-NHCOCH2NH-) | |||
| Galb1-3(Neuca2-6)GalNAca-PAA-fluor. | 03-113 | 0.2 mg | |
| Galb1-3(Neucb2-6)GalNAca-PAA-fluor. | 03-114 | 0.4 mg | |
| Neuca2-3(Neuca2-6)GalNAca-PAA-fluor. | 03-115 | 0.2 mg | |
| Galb1-4GlcNAcb1-3GalNAca-PAA-fluor. | 03-116 | 0.4 mg | |
| Galb1-4GlcNAcb1-6GalNAca-PAA-fluor. | 03-117 | 0.4 mg | |
| 四糖或更多低聚糖（Tetra- and more Oligosaccharides） | |||
| Leb-PAA-fluor. | 03-042 | 0.4 mg | |
| Ley-PAA-fluor. | 03-043 | 0.4 mg | |
| Sialyl Lea-PAA-fluor. | 03-044 | 0.2 mg | |
| Sialyl Lex-PAA-fluor. | 03-045 | 0.2 mg | |
| GlcNAcb1-3(GlcNAcb1-6)Galb1-4Glcb-PAA-fluor. | 03-090 | 0.4 mg | |
| GalNAca1-3(Fuca1-2)Galb1-4GlcNAc-PAA-fluor. | 03-091 | 0.4 mg | |
| Gala1-3(Fuca1-2)Galb1-4GlcNAc-PAA-fluor. | 03-092 | 0.4 mg | |
| Gala1-3Galb1-4(Fuca1-3)GlcNAcb-PAA-fluor. | 03-093 | 0.4 mg | |
| Neuca2-3(6-HSO3)Galb1-4(Fuca1-3)GlcNAcb-PAA-fluor. (6Gal-HSO3-SiaLex) | 03-094 | 0.2 mg | |
| Neuca2-3Galb1-4(Fuca1-3)(6-HSO3)GlcNAcb-PAA-fluor. (6GlcNAc-HSO3-SiaLex) | 03-095 | 0.2 mg | |
| Galb1-3GlcNAcb1-3Galb1-4GlcNAcb-PAA-fluor. | 03-096 | 0.2 mg | |
| Galb1-3GlcNAcb1-3Galb1-4Glcb-PAA-fluor. | 03-097 | 0.2 mg | |
| Galb1-4GlcNAcb1-3Galb1-4Glcb-PAA-fluor. | 03-098 | 0.2 mg | |
| (Neuc)5-6-sp-PAA-fluor. | 03-100 | 0.4 mg | |
| Gala1-3(Gala1-4)Galb1-4GlcNAcb-PAA-fluor. | 03-118 | 0.4 mg | |
| GalNAca1-4(Fuca1-2)Galb1-4GlcNAcb-PAA-fluor. | 03-119 | 0.4 mg | |
| GalNAcb1-3(Fuca1-2)Galb1-4GlcNAcb-PAA-fluor. | 03-120 | 0.4 mg | |
| Gala1-4(Fuca1-2)Galb1-4GlcNAcb-PAA-fluor. | 03-121 | 0.4 mg | |
| GlcNAcb1-3(GlcNAcb1-6)GlcNAcb1-4GalNAca-PAA-fluor. | 03-122 | 0.4 mg | |
| Galb1-3(Galb1-4GlcNAcb1-6)GalNAca-PAA-fluor. | 03-123 | 0.4 mg | |
| Fuca1-2(Galb1-4GalNAca1-3)Galb1-4GlcNAcb-PAA-fluor. | 03-124 | 0.4 mg | |
| Galb1-4GlcNAcb1-3(Galb1-4GlcNAcb1-6)GalNAca-PAA-fluor. | 03-125 | 0.4 mg | |
| (SA2-6G-GN-M)2-3,6-M-GN-GNb-PAA-fluor. | 03-126 | 0.2 mg | |
| sp=-NHCOCH2NH- | |||
| SA=Neuc, G= Gal, GN=GlcNAc, M=Man | |||
| 親和電泳用的碳水化合物聚合物（Carbohydrate Polymers for Affinity Electrophoresis） | |||
| 品名 | 貨號 | 規(guī)格 | |
| Neoglycoconjugates Set Properties: conjugates are able to copolymerise with acrylamide in standard conditions of electrophoretic gel polymerization, thus forming affinity gels. Use: for separation of lectins and anti-carbohydrate antibodies simultaneously on both electrophoretic and affinity principles,in standard conditions, using standard equipment. | 05-100 | 7x5 mg | |
| 人或牛血清白蛋白碳水化合物綴合物（Human or Bovine Serum Albumin Carbohydrate Conjugates） | |||
| APE coupling（圖1） | |||
| Product Name | 貨號 | 規(guī)格 | |
| Di-Le(x)-APE-BSA | 07-001 | 0.5 mg | |
| Di-Le(x)-APE-HSA | 07-002 | 0.5 mg | |
| H-type II-APE-HSA | 07-003 | 0.25 mg | |
| Gala1-3Galb-APE-HSA | 07-004 | 0.5 mg | |
| Le(y)-APE-HSA | 07-005 | 0.5 mg | |
| APD coupling（圖2） | |||
| Product Name | 貨號 | 規(guī)格 | |
| 3’Sialyllactose-APD-HSA | 07-006 | 0.5 mg | |
| 6’Sialyllactose-APD-HSA | 07-007 | 0.5 mg | |
| LNF I-APD-HSA | 07-008 | 0.5 mg | |
| LNF II-APD-HSA | 07-009 | 0.5 mg | |
| LNF III-APD-HSA | 07-010 | 0.5 mg | |
| Sia-Le(a)-APD-HSA | 07-011 | 0.25 mg | |
| Sia-LNF V-APD-HSA | 07-012 | 0.25 mg | |
| Fuc, Sia-LNnH-APD-HSA | 07-013 | 0.25 mg | |
| 碳水化合物和試劑（Carbohydrates and Reagents） | |||
| Complex Carbohydrates | |||
| 品名 | 貨號 | 規(guī)格 | |
| 2’-Fucosyllactose | 00-001 | 1 mg | |
| 3-Fucosyllactose | 00-002 | 1 mg | |
| Lactodifucotetraose (Difucosyllactose) | 00-003 | 1 mg | |
| LcOse 4 (LNT) ( Lacto-N-tetraose) | 00-004 | 1 mg | |
| IV2Fuc-LcOse4 (LNF I) (Lacto-N-fucopentaose I) | 00-005 | 1 mg | |
| (IV2Fuc,III4-LcOse4 ) (LND I) ( Lacto-N-difucohexaose I) Leb hexasaccharide | 00-006 | 1 mg | |
| 品名 | 貨號 | 規(guī)格 | |
| (III3Fuc-nLcOse4 ) (LNF III) ( Lacto-N-fucopentaose III) Lex-pentasaccharide | 00-007 | 0.5 mg | |
| Monofucosyllacto-N-hexaose | 00-008 | 100 µg | |
| Difucosyllacto-N-neohexaose | 00-009 | 100 µg | |
| Difucosyllacto-N-neohexaose (b) | 00-010 | 100 µg | |
| V4Fuc, III3Fuc-LcOse6 (Difucosyl-para-lacto-N-hexaose) | 00-011 | 100 µg | |
| Dimeric LexV3Fuc, III3Fuc-LcOse6 (Difucosyl-para-lacto-N-neohexaose) | 00-012 | 100 µg | |
| 品名 | 貨號 | 規(guī)格 | |
| Trifucosyllacto-N-hexaose | 00-013 | 100 µg | |
| Leb-Lex Trifucosyl-para-lacto-N-hexaose (TFpLNH) | 00-014 | 100 µg | |
| 3’-Sialyllactose | 00-015 | 1 mg | |
| 6’-Sialyllactose | 00-016 | 1 mg | |
| LST a IV3NeuAc-LcOse4 (LS-tetrasaccharide a) (Sialyllacto-N-tetraose a) | 00-017 | 500 µg | |
| LST b III6NeuAc-LcOse4 (LS-tetrasaccharide b) (Sialyllacto-Ntetraose b) | 00-018 | 500 µg | |
| 品名 | 貨號 | 規(guī)格 | |
| Monofucosyl, monosialyllactose (II3NeuAc, I3Fuc-Lac) | 00-019 | 100 µg | |
| Sialyl LNF VI IV6NeuAc, I3Fuc-nLcOse6 (Monosialyl, monofucosyllacto-N-neotetraose) | 00-020 | 100 µg | |
| Disialyllacto-N-tetraose (IV3NeuAc, III6NeuAc-LcOse4 ) | 00-021 | 1 mg | |
| A-pentasaccharide | 00-022 | 100 µg | |
| II2Fuc, I3Fuc-iGbOse3 (B-pentasaccharide) | 00-023 | 100 µg | |
| Oligomannose-3 (MAN-3) | 00-024 | 100 µg | |
| 品名 | 貨號 | 規(guī)格 | |
| Oligomannose-5 (MAN-5) | 00-025 | 100 µg | |
| Oligomannose-6 (MAN-6) | 00-026 | 100 µg | |
| Oligomannose-7D1 (MAN-7D1) | 00-027 | 20 µg | |
| Oligomannose-7D2 (MAN-7D2) | 00-028 | 20 µg | |
| Oligomannose-7D3(MAN-7D3) | 00-029 | 20 µg | |
| Oligomannose-8D1D3 (MAN-8D1D3) | 00-030 | 20 µg | |
| 品名 | 貨號 | 規(guī)格 | |
| Oligomannose-8D1D2 (MAN 8D1D2) | 00-031 | 20 µg | |
| Oligomannose-8D2D3 (MAN-8D2D3) | 00-032 | 20 µg | |
| Oligomannose-9 | 00-033 | 100 µg | |
| Asialo-biantennary (NA-2) | 00-034 | 100 µg | |
| Asialo-biantennary With Core Substituted Fucose (NA2F) | 00-035 | 20 µg | |
| Disialyl-biantennary (A2) | 00-036 | 20 µg | |
| 品名 | 貨號 | 規(guī)格 | |
| Oligomannose-3 Substituted with Fucose and Xylose (M3N2FX) | 00-037 | 20 µg | |
| Oligomannose-2(a) (MAN-2a) | 00-038 | NA | |
| Oligomannose-4 (MAN-4) | 00-039 | NA | |
| Lacto-N-hexaose (LNH) | 00-040 | 0.5 mg | |
| Lacto-N-neohexaose (LNnH) | 00-041 | 0.5 mg | |
| Monosialyl LNnH | 00-042 | 0.5 mg | |
| 品名 | 貨號 | 規(guī)格 | |
| Monosialyl, monofucosyl LNnH | 00-043 | 1 mg | |
| Disialyl, monofucosyl LNH | 00-044 | 0.5 mg | |
| 00-045 to 046 (Repeating ß1-4GlcNAc ) | |||
| n=1 Chitobiose | 00-045 | 1 mg | |
| n=2 Chitotriose | 00-046 | 1 mg | |
| n=3 Chitotetraose | 00-047 | 1 mg | |
| 00-048 to 051 (Repeating 1-4Glc ) | |||
| n=2 Maltotriose | 00-048 | 100 mg | |
| n=3 Maltotetrarose | 00-049 | 50 mg | |
| n=4 Maltopentaose | 00-050 | 50 mg | |
| n=5 Maltohexaose | 00-051 | 50 mg | |
| Carbohydrate Analogs and Reagents | |||
| Glycoamino Acids | |||
| 品名 | 貨號 | 規(guī)格 | |
| tetra-O-acetyl-Glc-ß-FMOC-Asn | 06-008 | 100 mg | |
| tri-O-acetyl-GalNAc-FMOC-Ser | 06-014 | 100 mg | |
| Sialic Acid Derivatives | |||
| 品名 | 貨號 | 規(guī)格 | |
| Neuc-methyl glycoside | 06-022 | 10 mg | |
| Neuc-benzyl glycoside | 06-024 | 10 mg | |
| Neucß-benzyl glycoside | 06-035 | 10 mg | |
| Neuc-methyl glycoside methyl ester | 06-025 | 10 mg | |
| Neuc-methyl ester | 06-036 | 10 mg | |
| 胞壁肽（Muramyl Peptides） | |||
| (N-Acetylmuramyl-L-alanyl-D-isoglutamine and derivatives) | |||
| 品名 | 貨號 | 規(guī)格 | |
| Muramyldipeptide (MDP) | 06-027 | 10 mg | |
| MDPß-hexadecyl glycoside | 06-029 | 10 mg | |
| 乙酰化糖（Acetylated Saccharides） | |||
| 品名 | 貨號 | 規(guī)格 | |
| α-D Glucose pentaacetate | 06-030 | 1 gm | |
| α-D Galactose pentaacetate | 06-032 | 1 gm | |
| ß-D Glucosamine pentaacetate | 06-034 | 1 gm | |
| 配套產(chǎn)品（Supporting Product） | |||
| 品名 | 貨號 | 規(guī)格 | |
| Polyisobutylmethacrylate beads | 40-006 | 5 gm | |
| 碳水化合物親和吸附劑（Carbohydrate Affinity Adsorbents） | |||
| 品名 | 貨號 | 規(guī)格 | |
| 雙糖(Disaccharides) | |||
| Blood type B: Gala1-3Galb-Adsorbent | 09-018 | 50 ml | |
| Galb1-3GalNAca-PAA-Adsorbent | 09-023 | 10 ml | |
| GalNAca1-3GalNAcb-Adsorbent | 09-026 | 10 ml | |
| 三糖(Trisaccharides) | |||
| Blood type A (tri)-Adsorbent | 09-032 | 50 ml | |
| Blood type B (tri)-Adsorbent | 09-033 | 50 ml | |
| GlcNAcb1-2Galb1-3GalNAca-Adsorbent | 09-076 | 50 ml | |
| Adsorbents made using SEPHAROSETM chromatography media. SEPHAROSE is a trademark of GE Healthcare companies | |||
| 抗體（Antibodies） | |||
| 品名 | 貨號 | 規(guī)格 | |
| Anti-Lex Isotype: IgM (BRA-4F1) | 10-008 | 200 µg | |
| Anti-E-selectin Isotype: IgG1 (7A9) | 11-002 | 200 µg | |
| Anti-MUC1 Isotype: IgG1 (VU-4H5) | 11-011 | 200 µg | |
| 腫瘤碳水化合物生物標(biāo)志物抗體（Antibodies to Carbohydrate Tumor Markers） | |||
| 品名 | 癌癥類型 | 貨號 | 規(guī)格 |
| CA19-9 Isotype: IgG1 (GSLA-2) | 腸胃癌和胰腺癌 | 11-009 | 200 ug |
| DUPAN-2 Isotype: IgM (DUPAN-2) | 腸胃癌和胰腺癌 | 11-010 | 200 ug |
| Anti-GM3 Isotype: IgG3 (DH2) | 黑色素瘤 | 10-011 | 200 ug |
| Anti-Lex Isotype: IgM (BRA-4F1) | 白血病 | 10-008 | 200 ug |
| Anti-Extended Lex Isotype: IgG1 (GELF31) | 乳腺癌 | 11-005 | 200 ug |
| Anti-Extended sialyl-Lex Isotype: IgM (FH6) | 卵巢癌 | 11-007 | 200 ug |
| Anti-Ley Isotype: IgG2a (BR55) | 乳腺癌 | 11-006 | 200 ug |
| Anti-Gb3 Isotype: IgM (1A4) | 淋巴瘤 | 11-008 | 200 ug |
| 細(xì)胞黏附裝置（Cell Adhesion Apparatus） | |||
| 平行板流動小室（Parallel Plate Flow Chambers） | Parallel plate flow chambers are used in dynamic studies of cell adhesion under well-defined shear forces. Various gasket sizes allow flexibility in experimental design to operate with limited quantities of cells and/or reagents. (Refer to Protocol 7) | ||
| 環(huán)形流動小室（適用于35mm培養(yǎng)皿）（Circular Flow Chamber (for 35mm tissue culture dishes)） | |||
| Circular Flow Chamber Kit, 貨號：31-001 (Technical Reference: Improvements to Parallel Plate Flow Chambers to Reduce Reagents and Cellular Requirements, Brown and Larson, BMC Immunology 2001, 2:9) | Flow Chamber Kit Includes: | ||
| Two flow decks | |||
| (cast acrylic with different inlet/outlet designs) | |||
| 8 silicon rubber gaskets (two of each size) | |||
| Flow Width = 0.25 cm, Thickness = 0.005 in | |||
| Flow Width = 0.25 cm, Thickness = 0.010 in | |||
| Flow Width = 0.50 cm, Thickness = 0.010 in | |||
| Flow Width = 1.00 cm, Thickness = 0.010 in | |||
| 24 polypropylene tubing connectors (six of each) | |||
| Threaded 1/16 in. straight and L-connectors | |||
| Male and Female taper luer to 1/16 in. connectors | |||
| Silastic™ laboratory tubing (1/16 in. ID x 10 ft.) | |||
| Replacement Gaskets and Coverslips for the Circular Flow Chamber | |||
| 貨號：31-002 | Four Gaskets (Flow Width = 0.25 cm, Thickness = 0.005 in) | ||
| 貨號：31-003 | Four Gaskets (Flow Width = 0.25 cm, Thickness = 0.010 in) | ||
| 貨號：31-004 | Four Gaskets (Flow Width = 0.50 cm, Thickness = 0.010 in) | ||
| 貨號：31-005 | Four Gaskets (Flow Width = 1.00 cm, Thickness = 0.010 in) | ||
| 貨號：31-008 | Circular Glass Coverslips (pack of 30, 35 mm, #2) | ||
| 長方形流動小室（適用于標(biāo)準(zhǔn)顯微鏡載玻片）（Rectangular Flow Chamber (for standard microscope slide)） | |||
| Rectangular Flow Chamber Kit, 貨號：31-010 | Flow Chamber Kit Includes: | ||
| One flow deck (cast acrylic) | |||
| 4 silicon rubber gaskets (two of each size) | |||
| Flow Width = 1.00 cm, Thickness = 0.005 in | |||
| Flow Width = 1.00 cm, Thickness = 0.010 in | |||
| 24 polypropylene tubing connectors (six of each) | |||
| Threaded 1/16 in. straight and L-connectors | |||
| Male and Female taper luer to 1/16 in. connectors | |||
| Silastic™ laboratory tubing (1/16 in. ID x 10 ft.) | |||
| Replacement Gaskets for the Rectangular Flow Chamber | |||
| 貨號：31-011 | Four Gaskets (Flow Width = 1.0 cm, Thickness = 0.005 in) | ||
| 貨號：31-012 | Four Gaskets (Flow Width = 1.0 cm, Thickness = 0.010 in) | ||
| 靜態(tài)條件下分析細(xì)胞粘附的洗滌小室（WASH CHAMBER for Assaying Cell Adhesion under Static Conditions） | |||
| Static Cell Adhesion Wash Chamber, 貨號：31-006 | The use of convenient multiwell plates to assay the adhesion of cells to immobilized molecules under static conditions is usually difficult due to the uncontrolled shear forces normally generated while washing the plate. | ||
| The Wash Chamber allows the wells of the multiwell plate to be washed by inversion in a liquid-filled environment. Unbound cells are separated from the wells by gravity thereby eliminating shear and the passage of the adherent cells through a liquid/air interface.(Refer to Protocol 8) | |||
| 用于研究TLC板上細(xì)胞黏附的小室（Chamber for Cell Adhesion on TLC Plates） | |||
| CELL ADHESION CHAMBER for TLC Plates, 貨號：31-007 | Cell surface carbohydrates act as specific recognition molecules for intercellular adhesion among certain cells. | ||
| Glycosphingolipids represent a group of cell surface glycoconjugates that are easily separated and analyzed by thin layer chromatography. The cell adhesion chamber was specifically designed to permit the assay of cell adhesion directly on glycosphingolipids separated on thin layer chromatograms. | |||
| Cells are centrifuged directly on the TLC plate to form immediate close contact with chromatographed glycosphingolipids. The position of the bound cells corresponds to the Rf value of the glycosphingolipid ligand which may be used for purification and structural characterization of the functional carbohydrate sequence.(Refer to Protocol 9) | |||
